| The Therapeutic Goods Administration (TGA) has granted provisional approval for the use of Moderna’s COVID-19 vaccine in children aged six to 11 years.
In a statement released this morning, the regulator said the vaccine should be administered in two 0.25mL doses at least 28 days apart - half the dosage recommended for individuals aged 12 years and older.
Further advice on the rollout of Spikevax to this age group will be provided to the Government by the Australian Technical Advisory Group on Immunisation (ATAGI).
More details in today's issue of Pharmacy Daily.
| 